Last $77.77 USD
Change Today -0.41 / -0.52%
Volume 949.8K
ALNY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - alnylam pharmaceuticals inc (ALNY)

Name (Connections)Board RelationshipsTitleKey Developments
John Clarke 111 RelationshipsFounder, Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee 
Kevin Starr 76 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee 
Marsha Fanucci 53 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 

Compensation Committee* - alnylam pharmaceuticals inc (ALNY)

Name (Connections)Board RelationshipsTitle
Steven Paul M.D. 137 RelationshipsDirector, Chairman of Compensation Committee and Member of Science & Technology Committee
Paul Schimmel Ph.D. 70 RelationshipsDirector, Member of the Scientific Advisory Board, Member of Compensation Committee and Member of Science & Technology Committee
Kevin Starr 76 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee
ALNY Compensation vs. Industry
669.5K
364.1K
Chief Executive Officer
252.1K
272.6K
Chief Financial Officer
500.0K
352.6K
Chief Operating Officer
Share price activity for ALNYLAM PHARMACEUTICALS INC (ALNY)
52 Week Price Performance
ALNY
Industry Average

Nominating Committee* - alnylam pharmaceuticals inc (ALNY)

Name (Connections)Board RelationshipsTitleKey Developments
John Clarke 111 RelationshipsFounder, Chairman, Chairman of Nominating & Corporate Governance Committee and Member of Audit CommitteeAlnylam Pharmaceuticals, Inc. Announces New Appointments
09/15/14
Dennis Ausiello M.D. 134 RelationshipsDirector, Member of the Scientific Advisory Board, Member of Nominating & Corporate Governance Committee and Member of Science & Technology CommitteeAlnylam Pharmaceuticals, Inc. Elects Amy W. Schulman as Class III Director
07/2/14
Marsha Fanucci 53 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteeVictor J. Dzau Intends to Resign from the Board of Directors of Alnylam Pharmaceuticals, Inc., Effective June 30, 2014
02/26/14

Corporate Governance Committee* - alnylam pharmaceuticals inc (ALNY)

Name (Connections)Board RelationshipsTitle
Dennis Ausiello M.D. 134 RelationshipsDirector, Chairman of Compensation Committee and Member of Science & Technology Committee
John Clarke 111 RelationshipsDirector, Member of the Scientific Advisory Board, Member of Compensation Committee and Member of Science & Technology Committee
Marsha Fanucci 53 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee
ALNY and Competitor
Insiders vs. External
Board
13%
87%
Alnylam Pharmaceuticals, Inc.
25%
75%
Silence Therapeutics plc
8%
92%
Prosensa Holding N.V.
0%
100%
Galena Biopharma, Inc.
20%
80%
Tekmira Pharmaceuticals Corporation
8%
92%
Regulus Therapeutics Inc.
Insiders
External Board Members

Advisory Committee* - alnylam pharmaceuticals inc (ALNY)

Name (Board Relationships)/Title Board Affiliations
Dennis Ausiello 134 Relationships
Director, Member of the Scientific Advisory Board, Member of Nominating & Corporate Governance Committee and Member of Science & Technology Committee
No other board affiliations
David Bartel 27 Relationships
Member of Scientific Advisory Board
No other board affiliations
Robert Langer 451 Relationships
Member of the Scientific Advisory Board
No other board affiliations
Judy Lieberman 29 Relationships
Member of Scientific Advisory Board
No other board affiliations
Daniel Rader 61 Relationships
Member of Scientific Advisory Board
No other board affiliations
Paul Schimmel 70 Relationships
Director, Member of the Scientific Advisory Board, Member of Compensation Committee and Member of Science & Technology Committee
No other board affiliations
Phillip Sharp 131 Relationships
Director, Member of the Scientific Advisory Board and Chairman of Science & Technology Committee
No other board affiliations
Markus Stoffel 25 Relationships
Member of Scientific Advisory Board
No other board affiliations
Thomas Tuschl 24 Relationships
Member of Scientific Advisory Board
No other board affiliations
Phillip Zamore 15 Relationships
Member of Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALNY:US $77.77 USD -0.41

ALNY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Galena Biopharma Inc $2.19 USD 0.00
Prosensa Holding NV $8.66 USD -0.07
Regulus Therapeutics Inc $7.02 USD -0.35
Silence Therapeutics PLC 212.00 GBp +6.00
Tekmira Pharmaceuticals Corp C$22.62 CAD -0.26
View Industry Companies
 

Industry Analysis

ALNY

Industry Average

Valuation ALNY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 166.6x
Price/Book 6.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 149.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALNYLAM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.